| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $48.5M | +5.3% |
| R&D Expense | $14.6M | -22.2% |
| SG&A Expense | $25.2M | -17.9% |
| Operating Income | -$28.9M | +46.8% |
| Interest Expense | $2.3M | -13.2% |
| Pre-tax Income | -$31.4M | +48.8% |
| Income Tax | $42K | -6.7% |
| Net Income | -$31.5M | +48.8% |
| EPS (Basic) | -$0.26 | +63.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.6M | +230.5% |
| Accounts Receivable | $8.8M | +21.3% |
| Inventory | $3.1M | -28.5% |
| Current Assets | $30.7M | +54.2% |
| Total Assets | $85.4M | +3.5% |
| Current Liabilities | $29.1M | +59.6% |
| Long-term Debt | $15.0M | -5.5% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | +37.3% |
| Investing Cash Flow | -$2.2M | +76.8% |
| Financing Cash Flow | $34.1M | +8.3% |
| $42.5M |
| -12.0% |
| Stockholders' Equity | $42.9M | +25.6% |